News
InvestorsHub on MSN39m
BeOne Medicines shares climb following positive EU backing for lung cancer therapyBeOne Medicines AG (NASDAQ:ONC) saw its stock rise 2.5% in pre-market trading after the European Medicines Agency (EMA) issued a favorable opinion on its cancer drug TEVIMBRA for early-stage lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback